Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Other Accumulated Expenses (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Other Accumulated Expenses of $2.99 million for Q2 2026, down 12.2% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Other Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025, Pelthos Therapeutics posted Other Accumulated Expenses of $3.84 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.4 million (Q1 2026), $3.84 million (Q4 2025) and $5.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pelthos Therapeutics 77.24 Mn -11.16 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.99 Mn
Mar 31, 2026 3.40 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 5.56 Mn
API Access

Pelthos Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PTHS&period=max&api_key=YOUR_API_KEY